These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36427777)

  • 1. The dominant logic of Big Tech in healthcare and pharma.
    Schuhmacher A; Haefner N; Honsberg K; Goldhahn J; Gassmann O
    Drug Discov Today; 2023 Feb; 28(2):103457. PubMed ID: 36427777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of technology giants' healthcare collaborations.
    Szigetvári G; Mesko B
    Mhealth; 2023; 9():17. PubMed ID: 37089272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engaging Through Awareness: Purpose-Driven Framework Development to Evaluate and Develop Future Business Strategies With Exponential Technologies Toward Healthcare Democratization.
    Barbazzeni B; Haider S; Friebe M
    Front Public Health; 2022; 10():851380. PubMed ID: 35692334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital health revolution: perfect storm or perfect opportunity for pharmaceutical R&D?
    Hird N; Ghosh S; Kitano H
    Drug Discov Today; 2016 Jun; 21(6):900-11. PubMed ID: 26821131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streaming the beautiful game: exploring big tech's growing presence in the soccer industry.
    Fakataulavelua A; Lang M; Moulard J
    Front Sports Act Living; 2023; 5():1156601. PubMed ID: 37457853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management.
    Rodwin VG; Fabre G; Ayoub RF
    Int J Health Policy Manag; 2018 Mar; 7(3):201-206. PubMed ID: 29524948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shaking Up Biotech/Pharma: Can Cues Be Taken from the Tech Industry?
    Wang CK
    SLAS Technol; 2017 Jun; 22(3):233-236. PubMed ID: 28298148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A knowledge management system for new drug submission by pharma-industries.
    Pinciroli F; Mottadelli S; Vinci M; Fabbro L; Gothager K
    Stud Health Technol Inform; 2004; 107(Pt 1):241-5. PubMed ID: 15360811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.
    Dierks RM; Bruyère O; Reginster JY; Richy FF
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):571-578. PubMed ID: 27653356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharma giants swap research programs.
    Cancer Discov; 2014 Jul; 4(7):OF3. PubMed ID: 25002632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent production is a prerequisite for successful exit of a biopharmaceutical company.
    Saotome C; Nakaya Y; Abe S
    Drug Discov Today; 2016 Mar; 21(3):406-9. PubMed ID: 26721189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability Evaluation of Web Mining in Healthcare E-Commerce towards Business Success and a derived Cournot Model.
    Damodharan P; Ravichandran CS
    J Med Syst; 2019 Jul; 43(8):268. PubMed ID: 31273541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobiotech in big pharma: a business perspective.
    Würmseher M; Firmin L
    Nanomedicine (Lond); 2017 Mar; 12(5):535-543. PubMed ID: 28178881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharma Summit 2010: competing in the future healthcare system.
    Kibble A
    IDrugs; 2010 Apr; 13(4):228-31. PubMed ID: 20373249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking the eHealth professionals' career pathways: A case of Gulf Cooperation Council countries.
    Zakaria N; Zakaria N; Alnobani O; AlMalki M; El-Hassan O; Alhefzi MI; Househ M; Jamal A
    Int J Med Inform; 2023 Feb; 170():104914. PubMed ID: 36521421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Industry Update: the latest developments in therapeutic delivery.
    Steinbach OC
    Ther Deliv; 2014 May; 5(5):505-9. PubMed ID: 24998270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 20. Rewriting the textbook for pharma: how to adapt and thrive in a digital, personalized and collaborative world.
    Jones CH; Madhavan S; Natarajan K; Corbo M; True JM; Dolsten M
    Drug Discov Today; 2024 Sep; 29(9):104112. PubMed ID: 39053620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.